The latest skin cancer and melanoma news
Researchers shed light on how to predict which skin cancer patients are most likely to respond to immunotherapy
An international team of UK and US scientists has discovered that the activity of macrophages…
Browsing: Melanoma and Skin Cancer
Scientists identify key mechanism in development of skin cancer
LMU researchers have discovered how the interplay between a key protein and an endolysosomal ion…
Novel immunotherapy combo shows promise in melanoma
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to…
Two studies reflect growing confidence in novel therapy for non-melanoma skin cancer
Non-melanoma skin cancer (NMSC) is the most common type of cancer. NMSC treatment can be…
Metformin: A potential game-changer in skin cancer treatment
Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making…
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
Researchers utilised specialised genomic technology at the University of Calgary, Canada, to enhance our understanding…
AI model that checks for skin cancer shows promise
Scientists in the East of England have developed a way of using artificial intelligence to…
Melanoma with drug resistance: Cause identified
Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing…
Breaking the trend: Skin cancer incidence in young adults declines
The risk of skin cancer, malignant melanoma, now appears to be decreasing in Sweden -…
Dysfunctional white blood cells linked to heightened melanoma risk
About 8 to 10 million Americans over age 40 have an overabundance of cloned white…